The main objective of the course was to strengthen capacity in EU Member States for control of healthcare-associated infections due to multidrug-resistant organisms (MDROs) in acute health care settings and to promote the broadest possible implementation of appropriate methods.
ECDC organised a meeting among invited experts to exchange cross-disciplinary perspectives on the issue of MMR vaccination refusal among the general European population.
Ebola viruses and Marburg virus are classified as biosafety level 4 (BSL-4) pathogens and require special containment and barrier protection measures, in particular for people taking care of infected patients or bodies.
2014 was the first year that Ebola viral haemorrhagic fever infections were notified in TESSy, prompted by an outbreak in West Africa. Several, mostly travel-related, cases were reported in Europe since. Latest data from the Annual epidemiological report
ECDC promotes the performance of external quality assessment (EQA) schemes, in which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine or reference laboratory methods. EQA schemes, or laboratory proficiency testing, provide information about the accuracy of different characterisation and typing methods as well as antimicrobial susceptibility testing (AST) and the sensitivity of the methods in place to detect a certain pathogen or novel resistance patterns.